Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment [Phase 3]

View source ↗

Summary

Phase 3 study evaluating irinotecan liposome injection with 5-FU/leucovorin and oxaliplatin versus nab-paclitaxel plus gemcitabine in previously untreated metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Gemcitabine (Gemcitabine)
• Irinotecan liposome injection (irinotecan liposome injection)
• Leucovorin (folinic acid)
• Nab-paclitaxel (paclitaxel protein-bound)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Ipsen | Conditions: Metastatic Adenocarcinoma of the Pancreas | Phase 3 | Status: COMPLETED | Results posted: 2024-03-13